Warfarin Sodium

Rivaroxaban in Idiopathic Membranous Nephropathy

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Gene-guided Warfarin for Anticoagulation Therapy

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation